2006
DOI: 10.1186/1471-2261-6-29
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection

Abstract: Background: Cardiac allograft rejection remains a significant clinical problem in the early phase after heart transplantation and requires frequent surveillance with endomyocardial biopsy. However, this is an invasive procedure, which is unpleasant for the patient and carries a certain risk. Therefore, a sensitive non-invasive biomarker of acute rejection would be desirable.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
1

Year Published

2008
2008
2016
2016

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 23 publications
0
17
1
Order By: Relevance
“…These subjects all had angiography-verified absence of coronary artery disease in any major myocardial coronary artery branch. Nonischemic left ventricle myocardial biopsies were obtained from 19 subjects 4 months after orthotopic heart transplantation as a routine check for graft rejection (49). Only biopsies without signs of rejection were used.…”
Section: Figurementioning
confidence: 99%
“…These subjects all had angiography-verified absence of coronary artery disease in any major myocardial coronary artery branch. Nonischemic left ventricle myocardial biopsies were obtained from 19 subjects 4 months after orthotopic heart transplantation as a routine check for graft rejection (49). Only biopsies without signs of rejection were used.…”
Section: Figurementioning
confidence: 99%
“…DNA microarrays were scanned with a confocal laser scanner (GeneArray scanner36 G2500A Hewlett Packard, Palo Alto, CA, USA). In the diet study, the scanned output files were analyzed with Affymetrix Microarray Suite Version 5.0 (MAS 5.0) software as previously described [27]. The raw data was globally scaled to an arbitrary target intensity value of 100.…”
Section: Dna Microarray Analysismentioning
confidence: 99%
“…As from those evidences, this chemokine seems by different aspects to be an optimal candidate to predict acute kidney and heart organ rejection before transplantation; conversely, post-transplant serum measurement showed no changes in CXCL10 associated with heart rejection [98]. Of note, CXCL10 does not relate with general systemic inflammation but with early critical response to the antigen [98].…”
Section: Cxcl10-cxcr3 Axis and Outcomementioning
confidence: 93%
“…Of note, CXCL10 does not relate with general systemic inflammation but with early critical response to the antigen [98]. Accordingly, C reactive protein, index of general inflammatory status, and N-terminal natriuretic peptide, marker of ventricular function, are unable to predict rejection and, indeed, are associated with later occurring complications, such as allograft vasculopathy development and all causes of mortality [96].…”
Section: Cxcl10-cxcr3 Axis and Outcomementioning
confidence: 99%